Medable said an independent analysis with Tufts Center for the Study of Drug Development (CSDD) found its Clinical Monitoring Agent can improve the efficiency of clinical research monitoring and potentially save drug companies millions in development costs. The AI tool reviews documentation for missing fields, detects discrepancies in trial paperwork, and tracks variables across sites.